Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | RELA | Q04206 | 2/20 | 0.46 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4765054 | 1.00 | TSHR (0.46) | TSHRMEN1KMT2ARELACTDSP1 | |
| SCHEMBL4244889 | 0.98 | RELA (0.48) | TSHRMEN1KMT2ARELACTDSP1 | |
| SCHEMBL15102329 | 0.92 | HDAC8 (0.44) | TSHRMEN1KMT2ARELACTDSP1 | |
| SCHEMBL19313179 | 0.92 | HDAC8 (0.44) | TSHRMEN1KMT2ARELACTDSP1 | |
| SCHEMBL14173988 | 0.92 | HDAC8 (0.44) | TSHRMEN1KMT2ARELACTDSP1 | |
| SCHEMBL863304 | 0.91 | ALDH1A1 (0.49) | TSHRMEN1KMT2ARELAALDH1A1 | |
| SCHEMBL279125 | 0.88 | TSHR (0.59) | TSHRMEN1KMT2ALTA4HALDH1A1 | |
| SCHEMBL439584 | 0.88 | TSHR (0.59) | TSHRMEN1KMT2ALTA4HALDH1A1 | |
| SCHEMBL14488604 | 0.88 | TSHR (0.59) | TSHRMEN1KMT2ALTA4HALDH1A1 | |
| SCHEMBL14174076 | 0.88 | TSHR (0.59) | TSHRMEN1KMT2ALTA4HALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1424942-B1 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | UNIV MONTANA STATE (US) | 2008-12-31 | — | — | EP | disclosed |
| EP-1424942-A4 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | UNIV MONTANA STATE (US) | 2005-11-23 | — | — | EP | disclosed |
| US-6953570-B2 | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy | MONTANA STATE UNIVERSITY (US) | 2005-10-11 | — | — | US | disclosed |
| EP-1424942-A1 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | Montana State University-Bozeman (US) | 2004-06-09 | — | — | EP | disclosed |
| US-20030105070-A1 | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy | NICKEL JOINT TRUST, THE | 2003-06-05 | — | — | US | disclosed |
| WO-2003017846-A1 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | MONTANA STATE UNIVERSITY-BOZEMAN (US) | 2003-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105070-A1 | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy | HMBS, PPOX, PAICS | TSHR 2459/4885MEN1 808/4885KMT2A 1700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.